Our History
PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a prominent European Venture Capital firm specializing in Life sciences.
PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design.
Our Mission
PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes.
Our unique expertise and technological know-how enable us to develop innovative, patented, safe and effective local therapies.
PK MED has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare (PKM-01), Osteoarthritis (PKM-011) and Hemoglobinopathies (PKM-02).
Our Board of Directors
Chairman
Our Management Team
Chief Executive Officer
Chief Financial Officer
Head of Research & Development
Head of Pharmaceutical Development
Head of Biostatistics and Clinical Development
